Learn / QGEN
NYSE: QGEN
Qiagen N.V. (QGEN) stock, explained like you're 5
Qiagen N.V. trades on the New York Stock Exchange under the ticker QGEN. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 9.4 billion dollars.
- Ticker
- QGEN
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Mid cap, about 9.4 billion dollars
Is Qiagen N.V. a small, medium or large cap company?
No. Qiagen N.V. is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 9.4 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Qiagen N.V. makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves QGEN stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Qiagen N.V. (QGEN) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- An estimated 10.7 million people developed tuberculosis in 2024. WHO warns funding cuts threaten care. (Stock Titan)
- The Technical Signals Behind (QGEN) That Institutions Follow (Stock Traders Daily)
- Qiagen (QGEN) Looks Fairly Valued As New AI Tools Aim To Speed Drug Discovery (Simply Wall Street)
- Qiagen N.V. (QGEN) Stock Forecasts (Yahoo Finance)
Follow QGEN in your daily brief
Each trading day at 5 PM ET we post what happened to Qiagen N.V. and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow QGEN
Questions about Qiagen N.V. stock
What does Qiagen N.V. do?
Qiagen N.V. trades on the New York Stock Exchange under the ticker QGEN. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 9.4 billion dollars.
What is the ticker symbol for Qiagen N.V.?
Qiagen N.V. trades under the ticker QGEN on the New York Stock Exchange.
What is Qiagen N.V.'s market cap?
Qiagen N.V. is a mid cap stock with a market cap of about 9.4 billion dollars.
How does Qiagen N.V. make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves QGEN stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow QGEN stock every day?
Add QGEN to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.